Previous research has shown that entinostat, a histone deacetylase inhibitor with the ability to prevent PAX3::FOXO1 transcription, is able to act in synergy with vincristine to prevent tumorigenesis in specific mouse models of ARMS (47). This evidence concerns the gene PAX3 and alveolar rhabdomyosarcoma.